NRIX · Forms 3, 4, 5
Insider trades at Nurix Therapeutics, Inc.
3 insiders sold $699K of Nurix Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Nurix Therapeutics, Inc. (NRIX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Gwenn Hansen | Chief Scientific Officer | Option exercise | 1,452 | $1.86 | $3K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Sell | 1,452 | $25.00 | $36K | Form 4 | |
| Julia P Gregory | Director | Option exercise | 22,583 | $1.86 | $42K | Form 4 | |
| Julia P Gregory | Director | Sell | 22,583 | $23.40 | $529K | Form 4 | |
| Christine Ring | Chief Legal Officer | Option exercise | 5,786 | $8.72 | $50K | Form 4 | |
| Christine Ring | Chief Legal Officer | Sell | 5,786 | $23.19 | $134K | Form 4 | |
| Christine Ring | Chief Legal Officer | Option exercise | 5,787 | $8.72 | $50K | Form 4 | |
| Christine Ring | Chief Legal Officer | Sell | 5,387 | $25.69 | $138K | Form 4 | |
| Christine Ring | Chief Legal Officer | Sell | 400 | $26.64 | $11K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Option exercise | 1,452 | $1.86 | $3K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Sell | 1,452 | $25.47 | $37K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Option exercise | 4,356 | $1.86 | $8K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Sell | 4,356 | $25.00 | $109K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Sell | 1,500 | $23.87 | $36K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Sell | 2,611 | $24.64 | $64K | Form 4 | |
| Houte Hans van | Chief Financial Officer | Sell | 1,794 | $23.89 | $43K | Form 4 | |
| Houte Hans van | Chief Financial Officer | Sell | 2,967 | $24.65 | $73K | Form 4 | |
| Christine Ring | Chief Legal Officer | Option exercise | 5,787 | $8.72 | $50K | Form 4 | |
| Christine Ring | Chief Legal Officer | Sell | 16,589 | $23.05 | $382K | Form 4 | |
| Houte Hans van | Chief Financial Officer | Option exercise | 3,750 | Form 4 | |||
| Houte Hans van | Chief Financial Officer | Option exercise | 2,858 | Form 4 | |||
| Houte Hans van | Chief Financial Officer | Option exercise | 3,572 | Form 4 | |||
| Houte Hans van | Chief Financial Officer | Sell | 2,845 | $23.38 | $67K | Form 4 | |
| Christine Ring | Chief Legal Officer | Option exercise | 3,750 | Form 4 | |||
| Christine Ring | Chief Legal Officer | Option exercise | 2,858 | Form 4 | |||
| Christine Ring | Chief Legal Officer | Option exercise | 3,572 | Form 4 | |||
| Christine Ring | Chief Legal Officer | Sell | 3,847 | $23.38 | $90K | Form 4 | |
| Gwenn Hansen | Chief Scientific Officer | Option exercise | 3,750 | Form 4 | |||
| Gwenn Hansen | Chief Scientific Officer | Option exercise | 2,858 | Form 4 | |||
| Gwenn Hansen | Chief Scientific Officer | Option exercise | 3,572 | Form 4 | |||
| Gwenn Hansen | Chief Scientific Officer | Sell | 3,847 | $23.38 | $90K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.